Abstract:OBJECTIVE: To evaluate the efficacy of conformal rediotherapy on brain metastases,and investigate prognostic factors.METHODS: All the 40 patients were treated with intracranial radiotherapy.The patients with more than two brain lesions received whole brain radiotherapy to DT 40-46 Gy/(20-23) fractions,while the dose for the ones with one or two lesions was boosted to DT 54-60 Gy/(27-30) fractions by three dimentional conformal radiotherapy(3D-CRT) after whole brain radiotherapy to DT 40 Gy/20 fractions.The patients with single brain metastases were directly received 3D-CRT to DT 54-60 Gy/(27-30) fractions.Thirty-four patients received chemoradiotherapy.Multivariate analysis was performed by the Cox regression proportional hazard model.RESULTS: For all the 40 patients,the clinical symptom remission rate was 92.5%(37/40).The whole response rate(RR) and clinical benefit rate(CBR) was 62.5%(25/40) and 97.5%(39/40) respectively.The median intracranial control time was 7.2 months,while 6 months and 1 year intracranial control rate was 47.5% and 10.0% respectively.The median survival time was 10.5 months,while 6 months,1 year and 2 year survival rate was 65.0%,25.0% and 5.0% respectively.The patients with comprehensive chemoradiotherapy tended to live longer than the ones with radiotherapy alone,but the statistic difference was not detected(P=0.290).Cox multivariate analysis showed that the independent prognostic factors for patients with brain metastases treated by 3D-CRT were KPS performance status,extracranial primary tumor status(P0.05).CONCLUSIONS: The conformal radiotherapy for patients with brain metastases can obviously release the clinical symptom,improve quality of life,and significantly increase the survival time.Performance status,extracranial primary tumor status are independent prognostic factors.

Conformal Radiotherapy and Prognosis of Patients with Brain Metastases